Position papers

MAGNIMS position papers

click on title to access pdf of article (only for member users)
otherwise click on pubmed link for full reference

Position papers published from 2010 to present time

 

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines  Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F; MAGNIMS Study Group. Lancet Neurol. 2016 Mar;15(3):292-303.
pubmed

 

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, De Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, Montalban X; MAGNIMS study group. Nat Rev Neurol. 2015 Aug;11(8):471-82.
pubmed

 

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis – establishing disease prognosis and monitoring patients Wattjes MP, Rovira À, Miller D, Yousry TA, Sormani MP, de Stefano MP, Tintoré M, Auger C, Tur C, Filippi M, Rocca MA, Fazekas F, Kappos L, Polman C, Frederik Barkhof, Xavier Montalban; MAGNIMS study group. Nat Rev Neurol. 2015 Oct;11(10):597-606.
pubmed

 

Recommendations to improve imaging and analysis in longitudinal MS studies Vrenken H, Jenkinson M, Horsfield MA, Battaglini M, van Schijndel RA, Rostrup E, Geurts JJ, Fisher E, Zijdenbos A, Ashburner J, Miller DH, Filippi M, Fazekas F, Rovaris M, Rovira A, Barkhof F, de Stefano N; MAGNIMS Study Group. J Neurol. 2013 Oct;260(10):2458-71.
pubmed

 

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F; MAGNIMS Study Group. Neurology. 2011 Feb 1;76(5):418-24.
pubmed

 

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O’Connor P, Montalban X, Miller DH, Filippi M. Nat Rev Neurol. 2011 Dec 6;8(1):13-21.
pubmed

 

MRI criteria for MS in patients with clinically isolated syndromes. Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A, Yousry T, Rovira A, Miller DH. Neurology. 2010 Feb 2;74(5):427-34
pubmed

 

 

Position papers published before 2010

 

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira A, Gass A, Enzinger C, Matthews PM, Arnold DL. Neurology. 2007 Nov 13;69(20):1942-52
pubmed

 

MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, Miller DH, Montalban X, Simon JH, Polman C, Filippi M. Lancet Neurol. 2006 Oct;5(10):841-52
pubmed

 

Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.  Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM, Montalban X, Polman CH. Ann Neurol. 2004 Aug;56(2):273-8
pubmed

 

Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. Horsfield MA, Barker GJ, Barkhof F, Miller DH, Thompson AJ, Filippi M.  J Magn Reson Imaging. 2003 Apr;17(4):389-97
pubmed

 

Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI. Ann Neurol. 2000 Jun;47(6):831-5
pubmed

 

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH. Neurology. 1999 Aug 11;53(3):448-56
pubmed

 

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Filippi M, Horsfield MA, Adèr HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH. Ann Neurol. 1998 Apr;43(4):499-506
pubmed

 

Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ. J Neurol. 1997 Feb;244(2):76-84
pubmed

 

Others useful guidelines & resources